| Mrs Maria Magdalena Earnhart, | |
|
1255 Highway 54 W, Fayetteville, GA 30214-4526 | |
| (770) 719-7000 | |
| Not Available |
| Full Name | Mrs Maria Magdalena Earnhart |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 15 Years |
| Location | 1255 Highway 54 W, Fayetteville, Georgia |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477782399 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mak Anesthesia Holdings, Llc | 4284917204 | 167 |
| Mak Anesthesia Northside Affiliates Llc | 7315203718 | 36 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
| Entity Name | Mak Anesthesia, Nw Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609202720 PECOS PAC ID: 4880820315 Enrollment ID: O20131111001715 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
| Entity Name | Mak Anesthesia Decatur Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720409147 PECOS PAC ID: 8224261433 Enrollment ID: O20140423001687 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
| Entity Name | Mak Anesthesia Tch, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730549676 PECOS PAC ID: 5890092910 Enrollment ID: O20160404001912 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
| Entity Name | Mak Anesthesia Holdings, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912452939 PECOS PAC ID: 4284917204 Enrollment ID: O20170216001563 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
| Entity Name | Mak Anesthesia Northside Affiliates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609390103 PECOS PAC ID: 7315203718 Enrollment ID: O20171116002499 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Maria Magdalena Earnhart, 524 Akers Ridge Dr Se, Atlanta, GA 30339-3217 Ph: (770) 595-8851 | Mrs Maria Magdalena Earnhart, 1255 Highway 54 W, Fayetteville, GA 30214-4526 Ph: (770) 719-7000 |
News Archive
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
A new heart valve ring appears to help congestive heart failure patients regain lost heart function, reversing the disease's effects on heart structure in two ways and easing their disabling symptoms, researchers reported here today at the 85th Annual Meeting of the American Association for Thoracic Surgery.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
In a new study presented at CHEST 2017, researchers from Columbia University Medical Center in New York aimed to determine if the associations between combustion-related air pollutant levels and urgent asthma care differed by neighborhood in New York City.
› Verified 4 days ago
Danielle Duncan, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 770-719-7000 | |
Callie Kennedy, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 770-719-7000 | |
Mr. Hugh Duggan, MS IN ANESTHESIA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 770-719-7000 | |
David P Wright, PA-AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 404-351-1745 Fax: 404-351-7121 | |
Joshua Gordon, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1255 Ga-54, Fayetteville, GA 30214 Phone: 770-719-7000 | |
Mr. Brett Joseph Kieffer, AA-S Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 770-719-7000 |